Skip to main content

Ampyra Side Effects

Generic name: dalfampridine

Medically reviewed by Drugs.com. Last updated on Jan 6, 2024.

Note: This document contains side effect information about dalfampridine. Some dosage forms listed on this page may not apply to the brand name Ampyra.

Applies to dalfampridine: oral tablet extended release.

Serious side effects of Ampyra

Along with its needed effects, dalfampridine (the active ingredient contained in Ampyra) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking dalfampridine:

More common

Less common

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking dalfampridine:

Symptoms of overdose

Other side effects of Ampyra

Some side effects of dalfampridine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to dalfampridine: oral tablet extended release.

Nervous system

Common (1% to 10%): Dizziness, headache, balance disorder, multiple sclerosis relapse, paresthesia, tremor

Uncommon (0.1% to 1%): Seizure, exacerbation of trigeminal neuralgia[Ref]

Gastrointestinal

Common (1% to 10%): Nausea, constipation, dyspepsia

Postmarketing reports: Vomiting[Ref]

Musculoskeletal

Common (1% to 10%): Back pain[Ref]

Respiratory

Common (1% to 10%): Nasopharyngitis, pharyngolaryngeal pain, dyspnea[Ref]

Genitourinary

Very common (10% or more): Urinary tract infection (12%)[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Anaphylaxis, angioedema, hypersensitivity[Ref]

Psychiatric

Common (1% to 10%): Insomnia, anxiety[Ref]

Other

Common (1% to 10%): Asthenia

Uncommon (0.1% to 1%): Chest discomfort[Ref]

Cardiovascular

Common (1% to 10%): Palpitations[Ref]

Dermatologic

Uncommon (0.1% to 1%): Rash, urticaria[Ref]

References

1. Product Information. Ampyra (dalfampridine). Acorda Therapeutics. 2010.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.